Literature DB >> 29787840

Cutaneous features and diagnosis of primary Sjögren syndrome: An update and review.

Preeti Jhorar1, Kristin Torre1, Jun Lu2.   

Abstract

Sjögren syndrome (SS) is an autoimmune connective tissue disorder (CTD) that principally affects the lacrimal and salivary glands. Although SS is 1 of the 3 most common autoimmune CTDs alongside systemic lupus erythematosus and progressive systemic sclerosis, it is the least researched CTD overall. SS poses a particular diagnostic challenge because it shares multiple clinical and immunologic features with other CTDs. However, there are some characteristic cutaneous clinical features that can precede the well-known sicca symptoms by years. By familiarizing themselves with these clinical features and having a high suspicion for SS, dermatologists can play an important role in the early diagnosis and treatment of this disease.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sjögren syndrome; annular erythema; anti-Ro (SS-A); cutaneous vasculitis; localized cutaneous nodular amyloidosis; sicca

Mesh:

Substances:

Year:  2018        PMID: 29787840     DOI: 10.1016/j.jaad.2018.05.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Cutaneous manifestations of acute kidney injury.

Authors:  Gavin A Esson; Amaani B Hussain; Simon J Meggitt; Nick J Reynolds; John A Sayer
Journal:  Clin Kidney J       Date:  2021-12-09

2.  Skin manifestations associated with systemic diseases - Part I.

Authors:  Ana Luisa Sampaio; Aline Lopes Bressan; Barbara Nader Vasconcelos; Alexandre Carlos Gripp
Journal:  An Bras Dermatol       Date:  2021-09-17       Impact factor: 1.896

3.  Exophytic plaque on the plantar foot.

Authors:  Yasmin Hadian; Catherine Tchanque-Fossuo; Sara E Dahle; Kaitlyn West; Marat Kazak; Haines Ely; Joshua M Schulman; R Rivkah Isseroff
Journal:  JAAD Case Rep       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.